Can Li

Institution
University of Hong Kong

Country
Hong Kong

Field
Engineering

Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.

(Photo: University of Hong Kong)

AWARDS
  • 2023 Croucher Tak Wah Mak Innovation Award

Related articles

Study: Chinese Herb Dihydromyricetin Stops Hangovers, Alcohol Dependency In Rats

UCLA researchers have shown that an ancient Chinese herbal drug stops hangovers and reduces alcohol dependency in rats.

Australia, New Zealand Are World’s Largest Users Of Cannabis & Amphetamines

Australia and New Zealand have the highest rates of cannabis and amphetamine use in the world, according to comprehensive research on illicit drug use.

Sinovac: Phase III Clinical Trial For Hand, Foot And Mouth Disease Vaccine

Chinese biopharmaceutical company Sinovac Biotech Ltd. has begun the Phase III clinical trial for its proprietary inactivated EV71 vaccine against hand, foot and mouth disease (HFMD).

Nepal’s Monsanto Seed Sovereignty Debate Highlights Need For Home-Grown Solutions

An effort by U.S. donors and Monsanto to partner with Nepal to boost local maize production with imported hybrid seeds has met civil society opposition calling - instead - for home-grown solutions.

World’s Tiniest Frog, Paedophryne Amauensis, Found In Papua New Guinea

Researchers have found two new frog species in New Guinea, one of which is the new smallest known vertebrate on Earth.

Australian Study To Assess Sativex As Cannabis Withdrawal Drug

Researchers are studying whether the pharmaceutical drug Sativex - registered for pain relief in multiple sclerosis patients - can help people better manage cannabis withdrawal symptoms as well.

Use Of Acupuncture By The U.S. Military To Treat Battlefield Injuries, PTSD

The United States Armed Forces is incorporating acupuncture, one of the oldest healing practices in the world, to assist in the medical care of its personnel.

SFJ Pharma To Conduct Phase III Trial Of Pfizer’s Axitinib Adjuvant Treatment In Asia

SFJ Pharma Ltd. will conduct a Phase III clinical trial in Asia of Pfizer's axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma following nephrectomy.

New Sugar-Based Treatment For Type 1 Diabetes Found

Researchers from The Australian National University have discovered a new treatment for Type-1 diabetes based on a sugar called heparan sulfate.